HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)

Completed

Conditions studied: Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome, Opiate Addiction, Drug Dependence

In brief

STRIDE2 is a longitudinal, non-randomized study of individuals living with HIV who are dependent on opioids. This study is funded by the National Institute on Drug Abuse (R01DA030768, Altice, PI; Taxman \& Lawson, Co-PIs) and is being conducted by George Mason University, Yale University, and Howard University.

Key facts

Study ID

NCT03583138

Run by

Yale University

People needed

159

Starts

2014-06-23

Expected to finish

2017-06-30

Last updated by the study team

2020-05-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV+, confirmed by rapid HIV test
• Meet DSM-IV criteria for opioid dependence
• 18 years or older
• Have health insurance that is accepted at Lab Corp.

You may not qualify if…

• Are <18 years old;
• Are HIV negative;
• Are Unable to communicate in English;
• Are not able to provide informed consent;
• Do not meet DSM-IV criteria for opioid dependence;
• Plan to leave the DC area

Where it is running

• Howard University — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.